Secondaries announced 6.10.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: BioPharmx Symbol: BPMX Price: $3.00-$3.00 Description: They are a specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to[…]